Urinary tract infection due to Achromobacter xylosoxidans: Report of 9 cases

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 2, 2008, Pages 84-87

  Tena, Daniel ^a   González Praetorius, Alejandro ^a   Pérez Balsalobre, Mercedes ^b   Sancho, Oliva ^c   Bisquert, Julia ^a  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b Medical Centre of Cabanillas del Campo   (Spain)

^c Medical Centre 'El Balconcillo'   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHRONIC KIDNEY FAILURE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYSTITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG SENSITIVITY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; KIDNEY GRAFT; MALE; MORBIDITY; MULTIDRUG RESISTANCE; PROGNOSIS; RECURRENT DISEASE; URINARY TRACT DISEASE; URINARY TRACT INFECTION;

ACHROMOBACTER DENITRIFICANS; ADULT; AGED; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; URINARY TRACT; URINARY TRACT INFECTIONS;

EID: 38149137361     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701558714     Document Type: Article

References (17)

1. Schreckenberger, PC, Daneshvar, MI, Weyant, RS and Hollis, DG. (2003) Acinetobacter, Achromobacter, Moraxella, and other non-fermentative Gram-negative rods. Manual of clinical microbiology, pp. 749-779. ASM Press, Washington D.C
2. Yabuuchi, E. and Oyama, A. (1971) Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol, 15, pp. 477-481.
3. Duggan, JM, Goldstein, SJ, Chenoweth, CE, Kauffman, CA and Bradley, SF. (1996) Achromobacter xylosoxidans bacteraemia: Report of 4 cases and review of the literature. Clin Infect Dis, 23, pp. 569-576.
4. Tena, D., Carranza, R., Barberá, JR, Valdezate, S., Garrancho, JM and Arranz, M. (2005) Outbreak of long-term intravascular catheter-related bacteraemia due to Achromobacter xylosoxidans subspecies xylosoxidans in a haemodialysis unit. Eur J Clin Microbiol Infect Dis, 24, pp. 727-732.
5. National Committee for Clinical Laboratory Standards (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard. National Committee for Clinical Laboratory Standards, Villanova, Pennsylvania
6. Garner, JS, Jarvis, R., Emori, TG, Horan, TC and Hughes, JM. (1988) CDC definitions for nosocomial infections. Am J Infect Control, 16, pp. 128-140.
7. Igra-Siegman, Y., Chmel, H. and Cobbs, C. (1980) Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol, 11, pp. 141-145.
8. Cieslak, TJ and Raszka, WV. (1993) Catheter-associated sepsis due to Alcaligenes xylosoxidans in a child with AIDS. Clin Infect Dis, 16, pp. 592-593.
9. Reina, J., Antich, M., Siquier, B. and Alomar, P. (1988) Nosocomial outbreak of Achromobacter xylosoxidans associated with a diagnostic contrast solution. J Clin Pathol, 41, pp. 920-923.
10. Gahrn-Hansen, B., Alstrup, P., Dessau, R., Fursted, K., Knudsen, A. and Olsen, H. (1988) Outbreak of infection with Achromobacter xylosoxidans from contaminated intravascular pressure transducers. J Hosp Infect, 12, pp. 1-6.
11. Aisenberg, G., Rolston, KV and Safdar, A. (2004) Bacteraemia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer, 101, pp. 2134-2140.
12. Shie, SS, Huang, CT and Leu, HS. (2005) Characteristics of Achromobacter xylosoxidans bacteraemia in northern Taiwan. J Microbiol Immunol Infect, 38, pp. 277-282.
13. van Horn, K., Gedris, CA, Ahmed, T. and Wormser, GP. (1989) Bacteraemia and urinary tract infection associated with CDC Group vd biovar 2. J Clin Microbiol, 27, pp. 201-202.
14. Reverdy, ME, Freney, J., Fleurette, J., Coulet, M., Surgot, M. and Marmet, D. (1984) Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol, 19, pp. 140-143.
15. Fass, RJ, Barnishan, J., Solomon, MC and Ayers, LW. (1996) In vitro activities of quinolones, β-lactams, tobramycin, and trimethoprim-sulfamethoxazole against non-fermentative Gram-negative bacilli. J Clin Microbiol, 40, pp. 1412-1418.
16. Senda, K., Arakawa, Y., Ichiyama, S., Nakashima, K., Ito, H. and Ohsuka, S. (1996) PCR detection of metallo-beta-lactamase gene (blaIMP) in Gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol, 34, pp. 2909-2913.
17. Saiman, L., Chen, Y., Gabriel, PS and Knirsch, C. (2002) Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother, 46, pp. 1105-1107.